跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,730 条关于
“cardiometabolic HFpEF”
全部
1,730
临床试验
1,228
药物
14
机构
1
资讯
487
去年
Ninerafaxstat Shows Promise in Phase 2 Trial for Cardiometabolic HFpEF Patients
去年
Real-World Evidence Demonstrates Superior Cardiovascular and Renal Benefits of GLP-1 Receptor Agonists in High-Risk Patients
25天前
Revier Therapeutics Launches with €6M Seed Financing to Pioneer Class IIa HDAC Inhibitors for Cardiometabolic Disease
去年
Tirzepatide Shows Promise in Phase III Trial for Heart Failure with Preserved Ejection Fraction
6个月前
iBio Advances Bispecific Antibody for Pulmonary Hypertension in Heart Failure, Targets Q3 2026 Development Candidate
上个月
Cellular Basis of HFpEF: Abnormal Lipids and the Emerging Role of Electronegative VLDL (V5)
去年
Tirzepatide Reduces Heart Failure Risk by 38% in HFpEF Patients with Obesity
去年
Tirzepatide Cuts Cardiovascular Risk in HFpEF Patients with Obesity
去年
Tirzepatide Reduces Heart Failure Risk in HFpEF Patients with Obesity: SUMMIT Trial
去年
Cytokinetics Initiates Phase 2 Trial of CK-586 for Heart Failure with Preserved Ejection Fraction
第 1 页,共 49 页
上一页
下一页